Conference
Phase II study of bay 43-9006 (SORAFENIB) in patients with chemo-naive hormone refractory prostate cancer (HRPC)
Authors
Chi KN; Ellard S; Hotte SJ; Czaykowski P; Moore M; Ruether JD; Hansen C; Seymour L
Volume
17
Pagination
pp. 152-152
Publisher
OXFORD UNIV PRESS
Publication Date
January 1, 2006
Name of conference
30th Congress of the European-Society-for-Medical-Oncology
Conference place
Istanbul, TURKEY
Conference start date
September 29, 2006
Conference end date
October 3, 2006
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534